110 related articles for article (PubMed ID: 26637848)
1. Innovative Therapeutic Strategies in the Treatment of Meningioma.
Caruso G; Elbabaa SK; Gonzalez-Lopez P; Barresi V; Passalacqua M; Caffo M
Anticancer Res; 2015 Dec; 35(12):6391-400. PubMed ID: 26637848
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in chemotherapy for meningiomas: a review.
Moazzam AA; Wagle N; Zada G
Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of recurrent meningiomas.
Chamberlain MC; Barnholtz-Sloan JS
Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease.
Rammo R; Rock A; Transou A; Raghunathan A; Rock J
J Neurosurg; 2016 Feb; 124(2):496-500. PubMed ID: 26274993
[TBL] [Abstract][Full Text] [Related]
5. Update on the therapeutic approaches to brain tumors.
Lallana EC; Abrey LE
Expert Rev Anticancer Ther; 2003 Oct; 3(5):655-70. PubMed ID: 14599089
[TBL] [Abstract][Full Text] [Related]
6. Targeted drug therapy for meningiomas.
Norden AD; Drappatz J; Wen PY
Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036
[TBL] [Abstract][Full Text] [Related]
7. New molecular targets in meningiomas: the present and the future.
Venur VA; Santagata S; Galanis E; Brastianos PK
Curr Opin Neurol; 2018 Dec; 31(6):740-746. PubMed ID: 30379704
[TBL] [Abstract][Full Text] [Related]
8. Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer.
Wilson TJ; Heth JA
J Clin Neurosci; 2012 Mar; 19(3):468-9. PubMed ID: 22245272
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy: What is its role in meningioma?
Sherman WJ; Raizer JJ
Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
13. High-grade meningiomas: new avenues for drug treatment?
Preusser M; Berghoff AS; Hottinger AF
Curr Opin Neurol; 2013 Dec; 26(6):708-15. PubMed ID: 24184974
[TBL] [Abstract][Full Text] [Related]
14. Intraarterial cisplatin plus intravenous doxorubicin for inoperable recurrent meningiomas.
Stewart DJ; Dahrouge S; Wee M; Aitken S; Hugenholtz H
J Neurooncol; 1995; 24(2):189-94. PubMed ID: 7562006
[TBL] [Abstract][Full Text] [Related]
15. Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management.
Wilson TA; Huang L; Ramanathan D; Lopez-Gonzalez M; Pillai P; De Los Reyes K; Kumal M; Boling W
Front Oncol; 2020; 10():565582. PubMed ID: 33330036
[TBL] [Abstract][Full Text] [Related]
16. Emerging systemic treatment options in meningioma.
Mair MJ; Berghoff AS; Brastianos PK; Preusser M
J Neurooncol; 2023 Jan; 161(2):245-258. PubMed ID: 36181606
[TBL] [Abstract][Full Text] [Related]
17. Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications.
Caruso G; Ferrarotto R; Curcio A; Metro L; Pasqualetti F; Gaviani P; Barresi V; Angileri FF; Caffo M
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760490
[TBL] [Abstract][Full Text] [Related]
18. Disseminated extracranial metastatic meningioma.
Chua FH; Low SY; Tham CK; Ding C; Wong CF; Nolan CP
J Clin Neurosci; 2016 Nov; 33():214-216. PubMed ID: 27515545
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapeutic options for atypical meningiomas.
Ahsan SA; Chendeb K; Profyris C; Teo C; Sughrue ME
Expert Opin Pharmacother; 2019 Oct; 20(15):1831-1836. PubMed ID: 31322413
[No Abstract] [Full Text] [Related]
20. Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.
Gupta V; Samuleson CG; Su S; Chen TC
Neurosurg Focus; 2007; 23(4):E9. PubMed ID: 17961046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
